1-20 of 23
hydroxyurea
Close
Sort by
Journal Articles

Osteonecrosis in sickle cell disease: an update on risk factors, diagnosis, and management

Oyebimpe O. Adesina, Lynne D. Neumayr
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 351–358.
https://doi.org/10.1182/hematology.2019000038
Published: 2019
Journal Articles

Sickle cell disease: a comprehensive program of care from birth

Mariane de Montalembert, Léon Tshilolo, Slimane Allali
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 490–495.
https://doi.org/10.1182/hematology.2019000053
Published: 2019
Journal Articles

Optimizing hydroxyurea therapy for sickle cell anemia

Russell E. Ware
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 436–443.
https://doi.org/10.1182/asheducation-2015.1.436
Published: 2015
Journal Articles

Does hydroxyurea prevent pulmonary complications of sickle cell disease?

Tyler W. Buckner, Kenneth I. Ataga
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 432–437.
https://doi.org/10.1182/asheducation-2014.1.432
Published: 2014
Journal Articles

Therapy for myeloproliferative neoplasms: when, which agent, and how?

Holly L. Geyer, Ruben A. Mesa
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 277–286.
https://doi.org/10.1182/asheducation-2014.1.277
Published: 2014
Journal Articles

Treating acute myeloid leukemia in older adults

Eunice S. Wang
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 14–20.
https://doi.org/10.1182/asheducation-2014.1.14
Published: 2014
Journal Articles

Reproductive issues in sickle cell disease

Kim Smith-Whitley
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 418–424.
https://doi.org/10.1182/asheducation-2014.1.418
Published: 2014
Journal Articles

Vaso-occlusion in sickle cell disease: pathophysiology and novel targeted therapies

Deepa Manwani, Paul S. Frenette
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 362–369.
https://doi.org/10.1182/asheducation-2013.1.362
Published: 2013
Journal Articles

What is the evidence that hydroxyurea improves health-related quality of life in patients with sickle cell disease?

Deepika S. Darbari, Julie A. Panepinto
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 290–291.
https://doi.org/10.1182/asheducation.V2012.1.290.3798273
Published: 2012
Journal Articles

Secondary Prevention of Overt Strokes in Sickle Cell Disease: Therapeutic Strategies and Efficacy

Michael R. DeBaun
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 427–433.
https://doi.org/10.1182/asheducation-2011.1.427
Published: 2011
Journal Articles

Primary Prophylaxis in Sickle Cell Disease: Is It Feasible? Is It Effective?

Alexis A. Thompson
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 434–439.
https://doi.org/10.1182/asheducation-2011.1.434
Published: 2011
Journal Articles

What Is the Evidence for Using Hydroxyurea for Secondary Stroke Prevention?

Jeffrey D. Lebensburger, Michael R. DeBaun, Alexis A. Thompson
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 440–442.
https://doi.org/10.1182/asheducation-2011.1.440
Published: 2011
Journal Articles

Management of Essential Thrombocythemia

Francisco Cervantes
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 215–221.
https://doi.org/10.1182/asheducation-2011.1.215
Published: 2011
Journal Articles

Advances in the use of hydroxyurea

Russell E. Ware, Banu Aygun
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2009) 2009 (1): 62–69.
https://doi.org/10.1182/asheducation-2009.1.62
Published: 2009
Journal Articles

Hemoglobin E Syndromes

Elliott Vichinsky
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2007) 2007 (1): 79–83.
https://doi.org/10.1182/asheducation-2007.1.79
Published: 2007
Journal Articles

Limitations of Clinical Trials in Sickle Cell Disease: A Case Study of the Multi-center Study of Hydroxyurea (MSH) Trial and the Stroke Prevention (STOP) Trial

Michael R. DeBaun, Joshua J. Field
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2007) 2007 (1): 482–488.
https://doi.org/10.1182/asheducation-2007.1.482
Published: 2007
Journal Articles

Induction of Fetal Hemoglobin in the Treatment of Sickle Cell Disease

Hassana Fathallah, George F. Atweh
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2006) 2006 (1): 58–62.
https://doi.org/10.1182/asheducation-2006.1.58
Published: 2006
Journal Articles

An Evidence-Based Approach to the Treatment of Adults with Sickle Cell Disease

Richard Lottenberg, Kathryn L. Hassell
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2005) 2005 (1): 58–65.
https://doi.org/10.1182/asheducation-2005.1.58
Published: 2005
Journal Articles

Management of Polycythemia Vera and Essential Thrombocythemia

Peter J. Campbell, Anthony R. Green
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2005) 2005 (1): 201–208.
https://doi.org/10.1182/asheducation-2005.1.201
Published: 2005
Journal Articles

Sickle Cell Disease

George R. Buchanan, Michael R. DeBaun, Charles T. Quinn, Martin H. Steinberg
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2004) 2004 (1): 35–47.
https://doi.org/10.1182/asheducation-2004.1.35
Published: 2004